JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB141772

SB-366791, TRPV1 antagonist

Be the first to review this product! Submit a review

|

(3 Publications)

MW 287.74 Da, Purity >99%. Potent, selective TRPV1 antagonist. Rapidly and reversibley inhibits capsaicin, acid, or heat mediated activation of human TRPV1 (IC50 values are 3 and 6 nM for capsaisin and heat respectively). Active in vivo.
.

View Alternative Names

Capsaicin receptor, DKFZp434K0220, OTRPC1, Osm-9-like TRP channel 1, TRPV1_HUMAN, Transient receptor potential cation channel subfamily V member 1, VR 1, Vanilloid receptor 1, Vanilloid receptor subtype 1

1 Images
Chemical Structure - SB-366791, TRPV1 antagonist (AB141772)
  • Chemical Structure

Lab

Chemical Structure - SB-366791, TRPV1 antagonist (AB141772)

2D chemical structure image of ab141772, SB-366791, TRPV1 antagonist

Key facts

CAS number

472981-92-3

Purity

>99%

Molecular weight

287.74 Da

Molecular formula

C<sub>1</sub><sub>6</sub>H<sub>1</sub><sub>4</sub>ClNO<sub>2</sub>

PubChem

667594

Nature

Synthetic

Solubility

Soluble in DMSO to 75 mM

Soluble in ethanol to 25 mM (with warming)

Biochemical name

N-(3-methoxyphenyl)-4-chlorocinnamanilide

Biological description

Potent, selective TRPV1 antagonist. Rapidly and reversibley inhibits capsaicin, acid, or heat mediated activation of human TRPV1 (IC50 values are 3 and 6 nM for capsaisin and heat respectively). Active in vivo.

Canonical smiles

COC1=CC=CC(=C1)NC(=O)C=CC2=CC=C(C=C2)Cl

Isomeric smiles

COC1=CC=CC(=C1)NC(=O)/C=C/C2=CC=C(C=C2)Cl

InChi

InChI=1S/C16H14ClNO2/c1-20-15-4-2-3-14(11-15)18-16(19)10-7-12-5-8-13(17)9-6-12/h2-11H,1H3,(H,18,19)/b10-7+

InChiKey

RYAMDQKWNKKFHD-JXMROGBWSA-N

IUPAC Name

(E)-3-(4-chlorophenyl)-N-(3-methoxyphenyl)prop-2-enamide

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
Ambient
Appropriate long-term storage conditions
Ambient
Storage information
The product can be stored for up to 12 months

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TRPV1 also known as the transient receptor potential vanilloid 1 or capsaicin receptor is a non-selective cation channel with a molecular mass of approximately 95 kDa. It acts mechanically by allowing the influx of calcium and sodium ions upon activation. This receptor is expressed predominantly in sensory neurons specifically in dorsal root ganglia and trigeminal ganglia which are key regions involved in pain perception. TRPV1 can also be found in various non-neuronal tissues influencing a range of physiological responses.
Biological function summary

The role of TRPV1 extends beyond sensory perception. It is involved in detecting and regulating body temperature and is activated by heat acidic conditions and certain lipid metabolites. The receptor operates as part of a homotetrameric complex contributing to neural signaling. It is activated by chemical ligands such as capsaicin the compound responsible for the spicy sensation in chili peppers influencing pain and inflammation pathways.

Pathways

TRPV1 plays essential roles in pain and nociception pathways. It intersects with the inflammatory pathway where its activity is modulated by protein kinase C (PKC) and phospholipase C (PLC). These pathways involve calcium signaling and relate to proteins such as PKA and calcineurin which modulate TRPV1 activity through phosphorylation and dephosphorylation affecting the body's response to noxious stimuli.

TRPV1 is a critical player in pain management and inflammatory disorders. It has been linked to chronic pain conditions like neuropathic pain and is also involved in migraine pathophysiology. In these contexts TRPV1 interacts with proteins like CGRP and TRPA1 which are also implicated in pain signaling and migraine mechanisms. Antagonists such as capsazepine AMG 9810 and AMG-517 have been researched for therapeutic targeting of TRPV1 in these disorders.

Product protocols

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

Molecules (Basel, Switzerland) 27: PubMed36364346

2022

Phytocannabinoid Compositions from Cannabis Act Synergistically with PARP1 Inhibitor against Ovarian Cancer Cells In Vitro and Affect the Wnt Signaling Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Nurit Shalev,Michelle Kendall,Seegehalli M Anil,Sudeep Tiwari,Hadar Peeri,Navin Kumar,Eduard Belausov,Ajjampura C Vinayaka,Hinanit Koltai

Molecules (Basel, Switzerland) 26: PubMed33477303

2021

Cannabis-Derived Compounds Cannabichromene and Δ9-Tetrahydrocannabinol Interact and Exhibit Cytotoxic Activity against Urothelial Cell Carcinoma Correlated with Inhibition of Cell Migration and Cytoskeleton Organization.

Applications

Unspecified application

Species

Unspecified reactive species

Omer Anis,Ajjampura C Vinayaka,Nurit Shalev,Dvora Namdar,Stalin Nadarajan,Seegehalli M Anil,Ofer Cohen,Eduard Belausov,Jacob Ramon,Einav Mayzlish Gati,Hinanit Koltai

Scientific reports 11:1462 PubMed33446817

2021

Cannabis compounds exhibit anti-inflammatory activity in vitro in COVID-19-related inflammation in lung epithelial cells and pro-inflammatory activity in macrophages.

Applications

Unspecified application

Species

Unspecified reactive species

Seegehalli M Anil,Nurit Shalev,Ajjampura C Vinayaka,Stalin Nadarajan,Dvora Namdar,Eduard Belausov,Irit Shoval,Karthik Ananth Mani,Guy Mechrez,Hinanit Koltai
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com